Quick Answer
Scinai Immunotherapeutics Ltd. reported Diluted EPS of $0.00 per share for fiscal year 2023.
Scinai Immunotherapeutics Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | $0.00 | -60.0% |
| 2022 | $0.01 | +150.0% |
| 2021 | -$0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | -$0.00 | +0.0% | +0.0% |
| March 31, 2022 | -$0.00 | — | — |
- Scinai Immunotherapeutics Ltd. showed a decrease of -60.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2023 period, Scinai Immunotherapeutics Ltd.’s diluted eps has grown by 120.0% (from $0.02 per share (loss) to $0.00 per share).
- The most recent figure is from Scinai Immunotherapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: